Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Praziquantel treatment frequency and liver fibrosis in Ugandan children with Schistosoma mansoni
ISRCTN16994599Phase 4Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of praziquantel in schistosomiasis mansoni (3 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Prevalence of periportal fibrosis. Started Feb 2020; status: completed.
02
Drugs
praziquantel
03
Conditions
schistosomiasis mansoni
Beyond the preview
Go deeper on ISRCTN16994599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16994599.